Chronic venous disease and the genetic influence

Phlebolymphology

Volumn 21, Issue 2, 2014, Pages 100-111

  Boisseau, Michel René ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Congenital; Familial; Genetics; Hereditary; Varicose veins; Venous ulcer

Indexed keywords

BLOOD CLOTTING FACTOR 13; FAS LIGAND; GELATINASE A; GELATINASE B; INTERLEUKIN 6; MACROPHAGE ELASTASE; NOTCH3 RECEPTOR; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P21; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR FOXC2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CADASIL; CELL INFILTRATION; CLINICAL TRIAL (TOPIC); ENVIRONMENTAL FACTOR; ETHNICITY; GENE MUTATION; GENETIC SCREENING; GENOTYPING TECHNIQUE; HEMOCHROMATOSIS; HEREDITY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFLAMMATION; IRON METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA; TWINS; ULCER; ULCER HEALING; VARICOSIS; VEIN DISEASE;

EID: 84896445046     PISSN: 12860107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F; VCP coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31:105-115.
2. Nicolaides AN, Allegra C, Bergan J, et al; American venous forum. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol. 2008;27:1-59.
3. Schmid-Schönbein GW. Molecular basis of venous insufficiency. In: Bergan J, ed. The Vein Book. London, UK: Elsevier Academic Press; 2007:67-78.
4. Pappas PJ, You R, Rameshwar P, et al. Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production. J Vasc Surg. 1999;30:1129-1145.
5. Bergan JJ, Schmid-Schönbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med. 2006;355:488-498.
6. Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology. 2008;23:85-98.
7. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005;6:221-234.
8. Kostas TI, Ioannou CV, Drygiannakis I, et al. Chronic venous disease progression and modification of predisposing factors. J Vasc Surg. 2010;51:900-907.
9. Gemmati D, Federici F, Catozzi L, et al. DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators. J Vasc Surg. 2009;50:1444-1451.
10. Leu HJ. Heredity of varicose disease. Rev Medicine. 1966;9:467-471.
11. Merlen JF, Coget J, Larere J. Heredity of varices. Phlebologie. 1967;20:213-216.
12. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175-184.
13. Hirai M, Naiki K, Nakayama R. Prevalence and risk factors of varicose veins in Japanese women. Angiology. 1990;41:228-232.
14. Fiebig A, Krusche P, Wolf A, et al. Heritability of chronic venous disease. Hum Genet. 2010;127:669-674.
15. Niermann H: Zwillingsdermatologie. 1 Vol Berlin, Springer-Verlag, 1964, p 32-33.
16. Brinsuk M, Tank J, Luft FC, Busjahn A, Jordan J. Heritability of venous function in humans. Arterioscler Thromb Vasc Biol. 2004;24:207-211.
17. Cornu-Thenard A, Boivin P, Baud JM, De Vincenzi I, Carpentier PH. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol.1994;20:318-326.
18. Zöller B, Ji J, Sundquist J, Sundquist K. Family history and risk of hospital treatment for varicose veins in Sweden. Br J Surg. 2012;99:948-953.
19. Laurikka JO, Sisto T, Tarkka MR, Auvinen O, Hakama M. Risk indicators for varicose veins in forty-to sixtyyears-olds in the Tempere varicose vein study. World J Surg. 2002;26:648-651.
20. Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risks factors for chronic venous insufficiency: a dual casecontrol study. J Vasc Surg. 1995;22:622-628.
21. Pistorius MA. Chronic venous insufficiency: the genetic influence. Angiology. 2003;54:S5-S12.
22. Ahti TM, Mäkivaara LA, Luukkaala T, Hakama M, Laurikka JO. Effect of family history on the risk of varicose veins is affected by differential misclassification. J Clin Epidemiol. 2010;63:686-690.
23. Gundersen J, Hauge M. Hereditary factors in venous insufficiency. Angiology. 1969;20:346-355.
24. Matousek V, Prerovsky I. A contribution to the problem of the inheritance of primary varicose veins. Hum Hered. 1974;24:225-235.
25. Guo Q, Guo C. Genetic analysis of varicose vein of lower extremities. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1998;15:221-223.
26. Serra R, Buffone G, de Franciscis A, et al. A genetic study of chronic venous insufficiency. Ann Vasc Surg. 2012;26:636-642.
27. Brice G, Mansour S, Bell R, et al. Analysis of the phenotypic abnormalities in lymphoedemadistichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet. 2002;39:478-483.
28. Criqui MH, Jamosmos M, Fronek A, et al. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol. 2003;158:448-456.
29. Purser JL, Kuchibhatla MN, Miranda ML, Blazer DG, Cohen HJ, Fillenbaum GG. Geographical segregation and IL6: a marker of chronic inflammation in older adults. Biomark Med. 2008;2:335-348.
30. Kakkos SK, Zolota VG, Peristeropoulou P, Apostolopoulou A, Geroukalos G, Tsolakis IA. Increased mast cell infiltration in familial varicose veins: pathogenetic implications? Int Angiol. 2003;22:43-49.
31. Degrave-Contour N. Le groupe sanguin A comme facteur de risque des varices des membres inférieurs: une enquête cas-témoins 395 cas. Thèse pour le Doctorat en Médecine. Faculté de Médecine Saint Antoine, Paris 1987. BDSP, ref 19529.
32. Sam RC, Burns PJ, Hobbs SD, et al. The prevalence of hyperhomocysteinemia, methylene reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency. J Vasc Surg. 2003;38:904-908.
33. Sansilvestri-Morel P, Rupin A, Jaisson S, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Synthesis of collagen in dysregulated cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation. 2002;106:479-483.
34. Sansilvestri-Morel P, Fioretti F, Rupin A, et al. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes? Clin Science. 2007;112:229-239.
35. Sansilvestri-Morel P, Rupin A, Badier-Commander C, Fabiani JN, Verbeuren TJ. Chronic venous insufficiency: dysregulation of collagen synthesis. Angiology. 2003;54:S3-8.
36. Sansilvestri-Morel P, Rupin A, Jullien ND, et al. Decreased production of collagen type III in cultured smooth muscle cells from varicose vein patients is due to degradation by MMPs: possible implication of MMP-3. J Vasc Res. 2005;42:388-398.
37. Filis K, Kavantzas N, Isopoulos T, et al. Increased vein wall apoptosis in varicose vein disease is related to venous hypertension. Eur J Vasc Endovasc Surg. 2011;41:533-539.
38. Ascher E, Jacob T, Hingorani A, Tsemekhin B, Gunduz Y. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lowerextremity varicose veins. J Vasc Surg. 2001;33:1080-1086.
39. Ducasse E, Giannakakis K, Speziale F, et al. Association of primary varicose veins with deregulated vein wall apoptosis. Eur J Vasc Endovasc Surg. 2008;35:224-229.
40. Yin H, Zhang X, Wang J, et al. Downregulation of desmuslin in primary vein incompetence. J Vasc Surg. 2006;43:372-378.
41. Le Flem L, Mennen L, Aubry ML, et al. Thrombomodulin promoter mutations, venous thrombosis, and varicose veins. Arterioscler Thromb Vasc Biol. 2001;21:445-451.
42. Zamboni P, Tognazzo S, Izzo M, et al. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg. 2005;42:309-314.
43. Tognazzo S, Gemmati D, Pallazzo A, et al. Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers. J Vasc Surg. 2006;44:815-819.
44. Saiki S, Sakai K, Saiki MD, et al. Varicose veins associated with CADASIL result from a novel mutation in the Notch3 gene. Neurology. 2006;67:337-339.
45. Mellor RH, Brice G, Stanton AW, et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limbs. Circulation. 2007;115:1912-1920.
46. Gordeuk VR, Sergueeva AI, Miasnikova GY, et al. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood. 2004;103:3924-3932.
47. Badauy CM, Gomes SS, Sant'Ana Filho M, Chies JA. Ehlers-Danlos syndrome (EDS) type IV: review of the literature. Clin Oral Investig. 2007;11:183-187.
48. Smith SE, Mullen TE, Graham D, Sims KB, Rehm HL. Norrie disease: extraocular clinical manifestations in 56 patients. Am J Med Genet A. 2012;158A:1909-1917.
49. Lee S, Lee W, Choe Y, et al. Gene expression profiles in varicose veins using complementary DNA microarray. Dermatol Surg. 2005;31:391-395.
50. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2005;111:2398-2409.
51. Shepherd AC, Lane TR, Davies AH. The natural progression of chronic venous disorders: an overview of available information from longitudinal studies. Phlebolymphology. 2012;19:138-147.
52. Franks PJ, Morton N, Campbell A, Moffatt CJ. Leg ulceration and ethnicity: a study in west London. Public Health. 1997;111:327-329.
53. Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK. Leg ulcers in sickle cell disease. Am J Hematol. 2010;85:831-833.
54. Bollinger A, Fagrell B. Clinical capillaroscopy, a guide to its use in clinical research and practice, 1st ed. Toronto, Canada:Hogrefe and Huber Publishers; 1990:31-52.
55. Simka M. Cellular and molecular mechanisms of venous leg ulcers development--the "puzzle" theory. Int Angiol. 2010;29:1-19.
56. Zamboni P, Izzo M, Tognazzo S, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Rad Biol Med. 2006;40:1869-1873.
57. Zamboni P, Gemmati D. Clinical investigations of gene polymorphisms in venous leg ulcer: a model of tissue injury and reparative process. Thromb Haemost. 2007;98:131-137.
58. Ashworth JJ, Smyth JV, Pendleton N, et al. Polymorphisms spanning the ON exon and promoter of the estrogen receptor beta (ER beta) gene ESR2 are associated with venous ulceration. Clin Genet. 2008;73:55-61.
59. Mackenzie RK, Ludlam CA, Ruckley CV, Allan PL, Burns P, Bradbury AW. The prevalence of thrombophilia in patients with chronic venous leg ulceration. J Vasc Surg. 2002;35:718-722.
60. Maessen-Visch MB, Hamulyak K, Tazelaar DJ, Crombag NH, Neumann HA. The prevalence of Factor V Leiden mutation in patients with leg ulcers and venous inufficiency. Arch Dermatol. 1999;135:41-44.
61. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P. Polymorphisms in the promoter regions of the MMP2, MMP3, MMP9 and MMP12 genes as determinants of aneurysmal coronary arterial disease. J Am Coll Cardiol. 2002;40:43-48.
62. Borghese B, Chiche JD, Vernerey D, et al. Genetic polymorphisms of matrix metalloproteinase 12 and 13 are implicated in endometriosis progression. Human Reprod. 2008,23:1207-1213.
63. Wallace HJ, Vandongen YK, Stacey MC. Tumor Necrosis factor alpha gene polymorphism associated with increased susceptibility to venous ulceration. J Invest Dermatol. 2006;126:921-925.
64. Nagy N, Szolnoky G, Szabad G, et al. Tumor Necrosis factor-alpha-308 polymorphism and leg ulcerationpossible association with obesity. J Invest Dermatol. 2007;127:1768.
65. Gemmati D, Tognazzo S, Catozzi L, et al. Influence of gene polymorphisms in ulcer healing process after superficial venous surgery. J Vasc Surg. 2006;44:554-562.
66. Fransén K, Fenech M, Fredrikson M, Dabrosin C, Söderkvist P. Association between ulcerative growth and hypoxia inducible factor-1 alpha polymorphisms in colorectal cancer patients. Mol Carcinog. 2006;45:833-840.
67. Cho YS, Bae JM, Chun YS, et al. HIF-1 alpha controls keratinocyte proliferation by up-regulating p21 (WAF1/Cip1). Biochem Biophys Acta. 2008;1783:323-333.
68. Anwar MA, Georgiadis KA, Shalhoub J, Lim CS, Gohel MS, Davies AH. Review of familial, genetic, and congenital aspects of primary varicose vein disease. Circ Cardiovasc Genet. 2012;5:460-466.
69. Cui C, Liu G, Huang Y, et al. Micro RNA profiling in great saphenous vein tissues of patients with chronic venous insufficiency. Tohoku J Exp Med. 2012;228:341-350.